Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI trial)

American Journal of Cardiology

Volumn 106, Issue 9, 2010, Pages 1218-1224

  Whrle, Jochen ^a   Desaga, Martin ^b   Metzger, Chris ^c   Huber, Kurt ^d   Suryapranata, Harry ^e   Guetta, Victor ^f   Guagliumi, Giulio ^g   Witzenbichler, Bernhard ^h   Parise, Helen ⁱ   Mehran, Roxana ⁱ   Stone, Gregg W ⁱ  

^a UNIVERSITY OF ULM   (Germany)

^b Klinikum Dachau der Amperkliniken AG   (Germany)

^c Heart Center   (United States)

^d WILHELMINEN HOSPITAL   (Austria)

^e HOSPITAL DE WEEZENLANDEN   (Netherlands)

^f SHEBA MEDICAL CENTER   (Israel)

^g OSPEDALI RIUNITI   (Italy)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; STREPTOKINASE; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY REPERFUSION; DRUG ELUTING STENT; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT TRANSFER; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78049303901     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.049     Document Type: Article

References (22)

1. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
2. R. Mehran, B. Brodie, D.A. Cox, C.L. Grines, B. Rutherford, D.L. Bhatt, G. Dangas, F. Feit, E.M. Ohman, H. Parise, M. Fahy, A.J. Lansky, and G.W. Stone The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56
3. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, M. Mckel, A. Ochala, A. Kellock, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
4. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
5. T.D. Henry, S.W. Sharkey, N. Burke, I.J. Chavez, K.J. Graham, C.R. Henry, D.L. Lips, J.D. Madison, K.M. Menssen, M.R. Mooney, M.C. Newell, W.R. Pedersen, A.K. Poulose, J.H. Traverse, B.T. Unger, Y.L. Wang, and D.M. Larson A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction Circulation 116 2007 721 728
6. H.R. Andersen, T.T. Nielsen, K. Rasmussen, L. Thuesen, H. Kelbaek, P. Thayssen, U. Abildgaard, F. Pedersen, J.K. Madsen, P. Grande, A.B. Villadsen, L.R. Krusell, T. Haghfelt, P. Lomholt, S.E. Husted, E. Vigholt, H.K. Kjaergard, L.S. Mortensen DANAMI-2 Investigators A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
7. M. Busk, M. Maeng, K. Rasmussen, H. Kelbaek, P. Thayssen, U. Abildgaard, E. Vigholt, L.S. Mortensen, L. Thuesen, S.D. Kristensen, T.T. Nielsen, H.R. Andersen DANAMI-2 Investigators The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up Eur Heart J 29 2008 1259 1266
8. B.R. Brodie, T.D. Stuckey, C.J. Hansen, D. VerSteeg, D. Muncy, M. Pulsipher, and N. Gupta Effect of treatment delay on outcomes in patients with acute myocardial infarction transferred from community hospitals for primary percutaneous coronary intervention Am J Cardiol 89 2002 1243 1247
9. A. Manari, P. Ortolani, P. Guastaroba, G. Casella, L. Vignali, E. Varani, G. Piovaccari, V. Guiducci, G. Percoco, S. Tondi, F. Passerini, A. Santarelli, and A. Marzocchi Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network Eur Heart J 29 2008 1834 1842
10. G.W. Stone Angioplasty strategies in ST-segment-elevation myocardial infarction Part I: primary percutaneous coronary intervention Circulation 118 2008 538 551
11. B.R. Brodie, C. Hansen, T.D. Stuckey, S. Richter, D.S. Versteeg, N. Gupta, W.E. Downey, and M. Pulsipher Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms J Am Coll Cardiol 47 2006 289 295
12. B.R. Brodie, T.D. Stuckey, T.C. Wall, G. Kissling, C.J. Hansen, D.B. Muncy, R.A. Weintraub, and T.A. Kelly Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 32 1998 1312 1319
13. B.R. Brodie, G.W. Stone, M.C. Morice, D.A. Cox, E. Garcia, L.A. Mattos, J. Boura, W.W. O'Neill, T.D. Stuckey, S. Milks, A.J. Lansky, C.L. Grines Stent Primary Angioplasty in Myocardial Infarction Study Group Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction trial) Am J Cardiol 88 2001 1085 1090 (Pubitemid 33043836)
14. A. Schmig, G. Ndrepepa, J. Mehilli, M. Schwaiger, H. Schhlen, S. Nekolla, J. Pache, S. Martinoff, H. Bollwein, and A. Kastrati Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis Circulation 108 2003 1084 1088 (Pubitemid 37071518)
15. M. Busk, A. Kaltoft, S.S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H.E. Botker, J.F. Lassen, E.H. Christiansen, L.R. Krusell, H.R. Andersen, T.T. Nielsen, and S.D. Kristensen Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 1272 h Eur Heart J 30 2009 1322 1330
16. G.W. Stone, S.R. Dixon, C.L. Grines, D.A. Cox, J.G. Webb, B.R. Brodie, J.J. Griffin, J.L. Martin, M. Fahy, R. Mehran, T.D. Miller, R.J. Gibbons, and W.W. O'Neill Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials Am J Cardiol 100 2007 1370 1375
17. B.J. Gersh, G.W. Stone, H.D. White, and D.R. Holmes Jr Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293 2005 979 986
18. R. Mehran, A.J. Lansky, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, S.C. Wong, E. Nikolsky, L. Gambone, L. Vandertie, H. Parise, G.D. Dangas, G.W. Stone HORIZONS-AMI Trial Investigators Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
19. M. Sejersten, S.L. Nielsen, T. Engstrøm, E. Jørgensen, and P. Clemmensen Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction Am J Cardiol 103 2009 1635 1640
20. P. Widimsky, T. Budesinsky, D. Vorc, L. Groch, M. Zelzko, M. Aschermann, M. Branny, J. St'sek, P. Formnek PRAGUE Study Group Investigators Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction Final results of the randomized national multicenter trialPRAGUE-2 Eur Heart J 24 2003 94 104
21. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators Primary versus tenecteplase facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction: ASSENT-4 PCI randomized trial (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) Lancet 367 2006 569 578
22. S.G. Ellis, M. Tendera, M.A. de Belder, A.J. van Boven, P. Widimsky, L. Janssens, H.R. Andersen, A. Betriu, S. Savonitto, J. Adamus, J.Z. Peruga, M. Kosmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobantu, L. Grinfeld, P. Armstrong, B.R. Brodie, H.C. Herrmann, G. Montalescot, F.J. Neumann, M.B. Effron, E.S. Barnathan, E.J. Topol FINESSE Investigators Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217